fund i — pre-seed & seed — confidential

Investing at the
Convergence of
Technology & Health

eteraflex connects ventures deploys early-stage capital into breakthrough technology and healthcare companies, with deep domain expertise and hands-on value creation that accelerates founders from seed to scale.

Pre-Seed & Seed
Stage Focus
Tech × Health
Sector Thesis
Fund I
Now Raising
Scroll
Enterprise AI Digital Health Vertical SaaS AI Diagnostics Cybersecurity Digital Therapeutics Developer Tools Genomics Synthetic Biology AI Drug Discovery Enterprise AI Digital Health Vertical SaaS AI Diagnostics Cybersecurity Digital Therapeutics Developer Tools Genomics Synthetic Biology AI Drug Discovery
Investment Thesis

Three Pillars,
One Conviction

Fund I deploys capital across three interconnected investment pillars, each grounded in secular megatrends reshaping the global economy.

Every investment must demonstrate large addressable markets, domain-expert founders, defensible moats, and capital efficiency to the next institutional round.

Pillar One
Technology
Enterprise AI, Vertical SaaS, Developer Tools, Cybersecurity, and Data Infrastructure. Targeting the application-layer explosion created by the foundation model platform shift.
Pillar Two
Healthcare
Digital Health, AI Diagnostics, Digital Therapeutics, Genomics, and Clinical Workflow. Deep sector expertise across healthcare and life sciences powers our diligence edge.
Pillar Three
Convergence: Tech × Health
AI Drug Discovery, Synthetic Biology, Health Data Marketplaces, Digital Biomarkers, and RegTech. The defining investment theme of the 2026–2035 decade.
Market Opportunity

Trillion-Dollar Tailwinds

Operating at the intersection of three secular megatrends: the enterprise AI revolution, digital transformation of healthcare, and Tech × Health convergence.

$190B
2030 Projected TAM
Enterprise AI & ML Platforms
Foundation models creating a new platform layer analogous to the mobile and cloud shifts, spawning thousands of application-layer startups.
CAGR 24%
$650B
2030 Projected TAM
Digital Health & Telehealth
$4.5 trillion US healthcare spend remains one of the least digitized industries. Regulatory tailwinds accelerating adoption permanently.
CAGR 15%
$65B
2030 Projected TAM
AI Diagnostics & Clinical AI
FDA's Software as Medical Device framework and CMS reimbursement expansion creating uniquely favorable regulatory environment.
CAGR 40%
$80B
2030 Projected TAM
Genomics & Precision Medicine
Programmable therapeutics, digital biomarkers from wearable data, and computational biology building defensible IP at the industry boundary.
CAGR 26%
Value Creation

We Don't Write Checks
and Wait

A structured operating system providing hands-on support across six dimensions that compress timelines and de-risk the path to Series A.

01
Talent & Recruiting
Executive recruiting network, fractional CXO introductions, compensation benchmarking, and org design frameworks.
Seed companies live or die on their first 10 hires.
02
Go-to-Market
Customer discovery workshops, pricing strategy, channel partnerships, and pilot program structuring.
Compressing time-to-PMF from 18 to 9 months.
03
Fundraising Prep
Series A readiness program: deck coaching, metrics dashboarding, warm introductions to 100+ Series A leads.
80% of seed companies fail at Series A. We de-risk this.
04
Regulatory & Clinical
FDA pathway mapping, HIPAA/SOC2 compliance frameworks, CMS reimbursement strategy, and IRB navigation.
Clear regulatory strategy means 2x faster fundraising.
05
Technical Architecture
Architecture review, AI/ML infrastructure guidance, scalability assessment, and security audit coordination.
Technical debt at seed compounds into Series A risk.
06
Strategic Partnerships
Health system pilot connections, enterprise customer warm introductions, and co-development agreement structuring.
Our network is a distribution channel for portfolio companies.
Pre-Seed Seed Fund I Technology Healthcare Convergence Value Creation Platform Vision Pre-Seed Seed Fund I Technology Healthcare Convergence Value Creation Platform Vision
Return Profile

Scenario Analysis

Fund I is structured to deliver strong risk-adjusted returns across multiple scenarios, driven by power-law portfolio construction.

Bear Case
2–3x
Gross MOIC
12–15%
Net IRR
Base Case
4–5x
Gross MOIC
22–28%
Net IRR
Bull Case
6–8x
Gross MOIC
30–40%
Net IRR
Breakout
10x+
Gross MOIC
40%+
Net IRR

Power Law Distribution

Expected return distribution across the portfolio

0x
Write-offs
1–3x
Base Returns
3–10x
Strong Performers
10–30x
Fund Makers
30x+
Fund Returners
Fund Terms

Structure & Terms

LP-friendly terms designed to align incentives over the full fund life.

Stage
Pre-Seed & Seed
Early-stage focus with follow-on reserves
Structure
LP-Friendly
European waterfall, preferred return, GP commitment
Geography
Global
US-focused with selective international exposure
Sectors
Tech × Health
Three-pillar thesis across convergence verticals
Portfolio
Concentrated
High-conviction positions across targeted verticals
Alignment
GP Commit
Meaningful skin in the game
Team

Domain Expertise
Meets Venture Craft

Our team brings deep operating experience across technology and healthcare, combined with institutional investment discipline.

General Partner
Technology & AI
Deep expertise in enterprise software, AI/ML, and developer platforms. Track record of identifying inflection points in platform shifts and the startups they enable.
General Partner
Healthcare & Life Sciences
Domain authority in digital health, clinical AI, and regulatory strategy. Extensive network across health systems, payers, and FDA pathways.
Venture Partner
Tech × Health Convergence
Bridging technology and healthcare at the boundary. Expertise in computational biology, health data infrastructure, and the emerging convergence opportunity.
Operating Partner
Value Creation & Operations
Hands-on operator building talent, GTM, and fundraising infrastructure that compresses portfolio company timelines from seed to Series A.
Vision

The Road to a
Premier Platform

Fund I is the foundation of a multi-decade venture platform built at the intersection of technology and healthcare.

2026
Fund I
Foundation
Proof of Concept
Establish the thesis, build proprietary deal flow, and prove the value creation model at pre-seed and seed.
2029
Fund II
Expansion
Platform Growth
Scale proven thesis, add Series A capability, grow team, and build institutional LP base from Fund I track record.
2032
Fund III
Multi-Stage
Full-Spectrum Platform
Seed-to-growth capability. Geographic expansion, dedicated sector funds, and a mature portfolio generating significant DPI.
2036+
Platform
Franchise
Definitive Tech × Health Platform
The premier venture platform at the convergence of technology and healthcare. Multi-geography, multi-stage, with category-defining portfolio companies.
Limited Partners

Partner With Us at the
Convergence

Fund I is open to qualified institutional and individual LPs aligned with our long-term vision at the intersection of technology and healthcare.

Request Materials
or reach us at lp@eteraflexconnects.com
Dubai
Princeton
Boston